Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 254

1.

The Impact of Changes in Medicare's Physician Payment System on Critical Care.

Hobson CE, Bihorac A, Hadian M, Herr DL, Rainey TG, Cerra FB, Napolitano LM, Hoyt JW.

Crit Connect. 2017 Feb;15:18-19.

2.

Team science as interprofessional collaborative research practice: a systematic review of the science of team science literature.

Little MM, St Hill CA, Ware KB, Swanoski MT, Chapman SA, Lutfiyya MN, Cerra FB.

J Investig Med. 2017 Jan;65(1):15-22. doi: 10.1136/jim-2016-000216. Epub 2016 Sep 12. Review.

3.

The United States National Center for Interprofessional Practice and Education: Integrating an informatics approach to interprofessional work.

Brandt BF, Cerra FB, Delaney CW.

J Interprof Care. 2015;29(6):592-5. doi: 10.3109/13561820.2015.1108736.

PMID:
26652632
4.

The National United States Center Data Repository: Core essential interprofessional practice & education data enabling triple aim analytics.

Pechacek J, Shanedling J, Lutfiyya MN, Brandt BF, Cerra FB, Delaney CW.

J Interprof Care. 2015;29(6):587-91. doi: 10.3109/13561820.2015.1075474.

5.

Commentary: educating the present and future health care workforce to provide care to populations.

Garr DR, Margalit R, Jameton A, Cerra FB.

Acad Med. 2012 Sep;87(9):1159-60.

PMID:
22929426
6.

Acute correction of hyponatremia secondary to psychogenic polydipsia.

Quinn CJ, Iyegha UP, Beilman GJ, Cerra FB.

Am J Case Rep. 2012;13:69-71. doi: 10.12659/AJCR.882772. Epub 2012 May 17.

7.

Academic medicine is doing more in health information technology than meets the eye.

Cerra FB, Delaney CW, Watson LA.

Acad Med. 2011 Apr;86(4):407. doi: 10.1097/ACM.0b013e31820dcb90. No abstract available.

PMID:
21451267
8.

Reshaping physician education.

Cerra FB.

Minn Med. 2010 Nov;93(11):33-4. No abstract available.

PMID:
21197881
9.
10.

A promising partnership.

Cerra FB.

Minn Med. 2003 Oct;86(10):13-5. No abstract available.

PMID:
14621938
11.

Near-infrared and nuclear magnetic resonance spectroscopic assessment of tissue energetics in an isolated, perfused canine hind limb model of dysoxia.

Beilman GJ, Myers D, Cerra FB, Lazaron V, Dahms RA, Conroy MJ, Hammer BE.

Shock. 2001 May;15(5):392-7.

PMID:
11336200
12.

Modulation of macrophage and B cell function by glycosaminoglycans.

Wrenshall LE, Stevens RB, Cerra FB, Platt JL.

J Leukoc Biol. 1999 Sep;66(3):391-400.

PMID:
10496308
13.

Enhanced cytochrome P450 IA1 activity of self-assembled rat hepatocyte spheroids.

Wu FJ, Friend JR, Remmel RP, Cerra FB, Hu WS.

Cell Transplant. 1999 May-Jun;8(3):233-46.

PMID:
10442736
14.

Development of a bioartificial liver device.

Hansen LK, Friend JR, Remmel R, Cerra FB, Hu WS.

Methods Mol Med. 1999;18:423-31. doi: 10.1385/0-89603-516-6:423.

PMID:
21370193
15.

Effect of pharmacokinetic sampling methods on aminoglycoside dosing in critically ill surgery patients.

Mann HJ, Wittbrodt ET, Baghaie AA, Cerra FB.

Pharmacotherapy. 1998 Mar-Apr;18(2):371-8.

PMID:
9545157
16.

Brain lactate by magnetic resonance spectroscopy during fulminant hepatic failure in the dog.

Nyberg SL, Cerra FB, Gruetter R.

Liver Transpl Surg. 1998 Mar;4(2):158-65.

17.

Frank B. Cerra, MD.

Cerra FB.

J Investig Med. 1997 Oct;45(8):416-22.

PMID:
9394093
18.

Characterization of the three-compartment gel-entrapment porcine hepatocyte bioartificial liver.

Sielaff TD, Nyberg SL, Rollins MD, Hu MY, Amiot B, Lee A, Wu FJ, Hu WS, Cerra FB.

Cell Biol Toxicol. 1997 Jul;13(4-5):357-64.

PMID:
9298256
19.

Applied nutrition in ICU patients. A consensus statement of the American College of Chest Physicians.

Cerra FB, Benitez MR, Blackburn GL, Irwin RS, Jeejeebhoy K, Katz DP, Pingleton SK, Pomposelli J, Rombeau JL, Shronts E, Wolfe RR, Zaloga GP.

Chest. 1997 Mar;111(3):769-78. No abstract available.

PMID:
9118718
20.

Development of a bioartificial liver employing xenogeneic hepatocytes.

Hu WS, Friend JR, Wu FJ, Sielaff T, Peshwa MV, Lazar A, Nyberg SL, Remmel RP, Cerra FB.

Cytotechnology. 1997 Jan;23(1-3):29-38. doi: 10.1023/A:1007906512616.

21.
22.

Hollow fiber bioartificial liver utilizing collagen-entrapped porcine hepatocyte spheroids.

Wu FJ, Friend JR, Lazar A, Mann HJ, Remmel RP, Cerra FB, Hu WS.

Biotechnol Bioeng. 1996 Oct 5;52(1):34-44.

PMID:
18629850
23.

The future. Monitoring cellular energetics.

Beilman GJ, Cerra FB.

Crit Care Clin. 1996 Oct;12(4):1031-42. Review.

PMID:
8902383
24.

Extrahepatic metabolism of 4-methylumbelliferone and lidocaine in the anhepatic rabbit.

Nyberg SL, Mann HJ, Hu MY, Payne WD, Hu WS, Cerra FB, Remmel RP.

Drug Metab Dispos. 1996 Jun;24(6):643-8.

PMID:
8781779
25.

Efficient assembly of rat hepatocyte spheroids for tissue engineering applications.

Wu FJ, Friend JR, Hsiao CC, Zilliox MJ, Ko WJ, Cerra FB, Hu WS.

Biotechnol Bioeng. 1996 May 20;50(4):404-15.

PMID:
18626989
26.

Mechanistics of formation and ultrastructural evaluation of hepatocyte spheroids.

Peshwa MV, Wu FJ, Sharp HL, Cerra FB, Hu WS.

In Vitro Cell Dev Biol Anim. 1996 Apr;32(4):197-203.

PMID:
8727043
27.

Evidence based critical care medicine; what is it and what can it do for us? Evidence Based Medicine in Critical Care Group.

Cook DJ, Sibbald WJ, Vincent JL, Cerra FB.

Crit Care Med. 1996 Feb;24(2):334-7. Review.

PMID:
8605810
28.

Review of support systems used in the management of fulminant hepatic failure.

McGuire BM, Sielaff TD, Nyberg SL, Hu MY, Cerra FB, Bloomer JR.

Dig Dis. 1995 Nov-Dec;13(6):379-88. Review.

PMID:
8590524
29.

Gel-entrapment bioartificial liver therapy in galactosamine hepatitis.

Sielaff TD, Hu MY, Amiot B, Rollins MD, Rao S, McGuire B, Bloomer JR, Hu WS, Cerra FB.

J Surg Res. 1995 Jul;59(1):179-84.

PMID:
7630125
30.

Effects of hepatocyte growth factor on viability and biotransformation functions of hepatocytes in gel entrapped and monolayer culture.

Hu MY, Cipolle M, Sielaff T, Lovdahl MJ, Mann HJ, Remmel RP, Cerra FB.

Crit Care Med. 1995 Jul;23(7):1237-42.

PMID:
7600833
31.

Formation of porcine hepatocyte spheroids for use in a bioartificial liver.

Lazar A, Peshwa MV, Wu FJ, Chi CM, Cerra FB, Hu WS.

Cell Transplant. 1995 May-Jun;4(3):259-68.

PMID:
7640865
32.

Extended liver-specific functions of porcine hepatocyte spheroids entrapped in collagen gel.

Lazar A, Mann HJ, Remmel RP, Shatford RA, Cerra FB, Hu WS.

In Vitro Cell Dev Biol Anim. 1995 May;31(5):340-6.

PMID:
7633671
33.

Distinct patterns of cyclin D1 regulation in models of liver regeneration and human liver.

Albrecht JH, Hu MY, Cerra FB.

Biochem Biophys Res Commun. 1995 Apr 17;209(2):648-55.

PMID:
7733934
34.

Entrapment of hepatocyte spheroids in a hollow fiber bioreactor as a potential bioartificial liver.

Wu FJ, Peshwa MV, Cerra FB, Hu WS.

Tissue Eng. 1995 Spring;1(1):29-40. doi: 10.1089/ten.1995.1.29.

PMID:
19877913
35.

Cardiovascular response to acute and chronic endotoxemia in an awake, volume-resuscitated, canine model.

Walvatne CS, Johnson AS, Wojcik LJ, Cerra FB.

Shock. 1995 Apr;3(4):299-306.

PMID:
7600197
36.

An anesthetized model of lethal canine galactosamine fulminant hepatic failure.

Sielaff TD, Hu MY, Rollins MD, Bloomer JR, Amiot B, Hu WS, Cerra FB.

Hepatology. 1995 Mar;21(3):796-804.

PMID:
7875678
37.

Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial.

Bower RH, Cerra FB, Bershadsky B, Licari JJ, Hoyt DB, Jensen GL, Van Buren CT, Rothkopf MM, Daly JM, Adelsberg BR.

Crit Care Med. 1995 Mar;23(3):436-49.

PMID:
7874893
38.

Heparan sulfate initiates signals in murine macrophages leading to divergent biologic outcomes.

Wrenshall LE, Cerra FB, Singh RK, Platt JL.

J Immunol. 1995 Jan 15;154(2):871-80.

PMID:
7814890
39.

A managed care model for home infusion therapy.

Cerra FB, Kaplan EL, Schwarzenberg SJ, Soltis R, Twiggs L.

Am J Med Qual. 1995 Summer;10(2):93-9.

PMID:
7787505
40.

Enhancement of cytochrome P450 function of collagen-entrapped hepatocytes by the addition of liver extracellular matrix components.

Hu MY, Sielaff TD, Cerra FB.

Transplant Proc. 1994 Dec;26(6):3293. No abstract available.

PMID:
7998136
41.
42.

Value of routine pressure monitoring system changes after 72 hours of continuous use.

O'Malley MK, Rhame FS, Cerra FB, McComb RC.

Crit Care Med. 1994 Sep;22(9):1424-30.

PMID:
8062565
43.

Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver.

Nyberg SL, Remmel RP, Mann HJ, Peshwa MV, Hu WS, Cerra FB.

Ann Surg. 1994 Jul;220(1):59-67.

44.

Modulation of cytolytic T cell responses by heparan sulfate.

Wrenshall LE, Carlson A, Cerra FB, Platt JL.

Transplantation. 1994 Apr 15;57(7):1087-94.

PMID:
8165708
45.
46.

Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience?

King LA, Carson LF, Konstantinides N, House MS, Adcock LL, Prem KA, Twiggs LB, Cerra FB.

Gynecol Oncol. 1993 Dec;51(3):377-82.

PMID:
8112649
47.

Hemodynamic, respiratory, and metabolic effects of laparoscopic cholecystectomy.

Goodale RL, Beebe DS, McNevin MP, Boyle M, Letourneau JG, Abrams JH, Cerra FB.

Am J Surg. 1993 Nov;166(5):533-7.

PMID:
8238748
48.

Evolution of the bioartificial liver: the need for randomized clinical trials.

Nyberg SL, Peshwa MV, Payne WD, Hu WS, Cerra FB.

Am J Surg. 1993 Nov;166(5):512-21. Review.

PMID:
8238746
49.

Extracorporeal application of a gel-entrapment, bioartificial liver: demonstration of drug metabolism and other biochemical functions.

Nyberg SL, Shirabe K, Peshwa MV, Sielaff TD, Crotty PL, Mann HJ, Remmel RP, Payne WD, Hu WS, Cerra FB.

Cell Transplant. 1993 Nov-Dec;2(6):441-52.

PMID:
8167929
50.

Supplemental Content

Loading ...
Support Center